Pacira Pharmaceuticals (PCRX) PT Raised to $54 at Cowen, Following Earnings

August 6, 2020 3:29 PM EDT
Get Alerts PCRX Hot Sheet
Price: $61.27 +0.33%

Rating Summary:
    14 Buy, 13 Hold, 1 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 10 | Down: 11 | New: 50
Trade Now! 
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Cowen analyst Borisk Peaker raised the price target on Pacira Pharmaceuticals (NASDAQ: PCRX) to $54.00 (from $44.00) while maintaining a Market Perform rating.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst PT Change

Related Entities

Cowen & Co, Earnings